- Research Resources
- Excellence in Science
- Excellence in Science FY25
Fiscal Year 2025 Awardees
Research is a cornerstone of MD Anderson¡¯s quest to end cancer. The Excellence in Science program is the online showcase for the Wall of Science, our quarterly program for honoring outstanding primary research selected from among publications in top journals by MD Anderson¡¯s world-renowned scientists.
Quarter 1 (September¨CNovember 2024)
Sangeeta Goswami
Nature Immunology
Histone lactylation drives CD8+ T cell metabolism and function
Associate Professor
Genitourinary Medical Oncology and Immunology
John Heymach and Ferdinandos Skoulidis
Professor and Chair, Thoracic/Head and Neck Medical Oncology
David Bruton, Jr. Chair
Associate Professor
Thoracic/Head and Neck Medical Oncology
Nature
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nicholas Navin
Nature
Normal breast tissues harbour rare populations of aneuploid epithelial cells
Chair and Professor
Systems Biology
The Grady F. Saunders, Ph.D. Distinguished Professorship for Molecular Biology
Kanwal Raghav
Kanwal Pratap Singh Raghav, M.B.B.S.
Associate Professor
GI Medical Oncology
Clinical Medical Director, Ambulatory Treatment Center
The Lancet Oncology
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
Katy Rezvani
Cancer Discovery
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3¦Æ/ZAP70 Signaling Axis
Sally Cooper Murray Chair in Cancer Research
Chief, Section of Cell Therapy
Medical Director GMP and Cell Therapy Facility
Professor, Stem Cell Transplantation and Cellular Therapy
Ferdinandos Skoulidis
Associate Professor
Thoracic/Head and Neck Medical Oncology
Cancer Discovery
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer
Chad Tang
Journal of Clinical Oncology
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial
Associate Professor
Radiation Oncology and Investigational Cancer Therapeutics
Peter Van Loo
Professor
Genetics
Cancer Discovery
The History of Chromosomal Instability in Genome-Doubled Tumors